Taken together, these data suggest that pharmacological stimulation of hERG1 potassium channel could be considered as potential therapeutic approach for treating breast cancers that may enhance the effectiveness of current drugs in overcoming therapeutic resistance. The gene discussed is KCNA3; the disease is breast carcinoma.